Fluanisone

CAS No. 1480-19-9

Fluanisone ( Fluanisone; 2028 MD; MD 2028; NSC 170977 )

Catalog No. M18045 CAS No. 1480-19-9

Fluanisone is a butyrophenone derivative with sedative properties. It is a typical antipsychotic and is used in the treatment of schizophrenia.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 30 In Stock
25MG 43 In Stock
50MG 83 In Stock
100MG 150 In Stock
200MG 240 In Stock
500MG 404 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fluanisone
  • Note
    Research use only, not for human use.
  • Brief Description
    Fluanisone is a butyrophenone derivative with sedative properties. It is a typical antipsychotic and is used in the treatment of schizophrenia.
  • Description
    Fluanisone is a typical antipsychotic and sedative of the butyrophenone chemical class. It is used in the treatment of schizophrenia and mania. It is also a component (along with fentanyl) of the injectable veterinary formulation fentanyl/fluanisone (Hypnorm) where it is used for rodent analgesia during short surgical procedures.
  • Synonyms
    Fluanisone; 2028 MD; MD 2028; NSC 170977
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1480-19-9
  • Formula Weight
    356.44
  • Molecular Formula
    C21H25FN2O2
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ccccc3OC
  • Chemical Name
    1-(4-fluorophenyl)-4-(4-(2-methoxyphenyl)piperazin-1-yl)butan-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Creese I,etal.Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.Science. 1976 Apr 30;192(4238):481-3.
molnova catalog
related products
  • Risperidone hydrochl...

    An antipsychotic agent with serotonin-S2 and dopamine-D2 antagonistic properties.

  • Sevoflurane

    Sevoflurane, a noncompetitive inhibitor of 5-HT3 receptor, acts as a low-soluble inhalation anesthetics.

  • Ro 67-7476

    Ro 67-7476 is a positive allosteric modulator of mGlu1 receptors. No activity at human mGlu1 receptors. Potentiates glutamate-induced calcium release with EC 50 of 60.1 nM.